BERLIN--(BUSINESS WIRE)--After receiving CE Mark approval last week, BIOTRONIK GmbH & Co. KG, the pioneer in wireless remote monitoring technology for patients with cardiac devices, announced today the world’s first implantations of the new Lumax 540 implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices in 11 hospitals in seven countries.
